Study guide

Psychosis assessment and antipsychotics

AMC CAT MCQ Examination AMC Part 1

Track your progress as you read

Finished sections get a check mark.

1 Acute Coronary Syndromes & ECG Localization

ACS recognition and ECG localisation Reperfusion and infarction complications

2 Heart Failure, Cardiogenic Shock & Cardiac Arrhythmias

Heart failure assessment and treatment Arrhythmias and conduction emergencies

3 Systemic Hypertension & Peripheral Vascular Disease

Blood pressure and cardiovascular risk Secondary hypertension and arterial disease

4 Valvular Heart Disease, Infective Endocarditis & Pericarditis

Aortic and mitral valve disease Endocarditis and pericardial emergencies

5 Asthma & COPD Acute Flares and Maintenance

Asthma and COPD diagnosis and maintenance Acute asthma and COPD exacerbations

6 Pneumonia, pleural disease and respiratory failure

Pneumonia and infected pleural collections Pulmonary embolism, effusions and pneumothorax Respiratory failure, ARDS and sepsis

7 GI bleeding, bowel inflammation and malabsorption

GI bleeding assessment and resuscitation Varices, ulcers, reflux and lower GI bleeding IBD patterns and severe colitis assessment IBD treatment, coeliac disease and IBS

8 Chronic Liver Disease, Cirrhosis Complications & Acute Hepatitis

Cirrhosis diagnosis and prognosis Decompensation, viral hepatitis and surveillance

9 Diabetes, thyroid and adrenal disease

Diabetes diagnosis and ongoing care DKA, HHS and complication monitoring Thyroid disease assessment Thyroid emergencies and adrenal disease

10 Acute Kidney Injury, Chronic Kidney Disease & Fluid/Electrolyte Emergencies

AKI and chronic kidney disease Potassium and sodium emergencies

11 Anaemias, Inflammatory Arthropathies & Geriatric Comprehensive Assessment

Anaemia, bruising and blood disorders Arthritis, autoimmune disease and geriatric care

12 Evaluation of the Acute Abdomen, Peritonitis & Appendicitis

Abdominal pain, peritonitis and resuscitation Appendicitis diagnosis and treatment Perforation and mesenteric ischaemia

13 Small and Large Bowel Obstruction & Colorectal Surgical Pathology

Small bowel obstruction Colonic obstruction, volvulus and cancer recognition Colorectal care, diverticulitis and anorectal symptoms

14 Gallbladder Disease, Biliary Tract Infections & Acute Pancreatitis

Gallstones and biliary obstruction Cholangitis and pancreatitis diagnosis Pancreatitis severity and treatment

15 Advanced Trauma Life Support, Primary Survey & Life-Threatening Thoracic Injuries

Trauma primary survey and adjuncts Chest trauma and immediate threats

16 Traumatic Brain Injury, Intracranial Haemorrhage & Spinal Cord Clearance

Head injury, imaging and haemorrhage Herniation and spinal cord injury

17 Major Fractures, Joint Dislocations & Acute Compartment Syndrome

Fracture assessment and open injuries Compartment syndrome, dislocations and pelvic injury

18 Thermal Burns, Haemorrhagic Shock Resuscitation & Surgical Wound Care

Burn assessment and fluid resuscitation Bleeding shock, wound care and tetanus

19 Aortic Aneurysms & Acute Arterial Limb Ischaemia

Aneurysm recognition and planned care Ruptured aneurysm and acute limb ischaemia

20 Urological Emergencies, Testicular Torsion & Haematuria Investigation

Retention, stones and obstructed infection Scrotal pain and haematuria

21 Preoperative Risk Stratification & Postoperative Surgical Complications

Preoperative assessment and medicines Postoperative complications and prevention

22 Early Pregnancy Bleeding, Ectopic Pregnancy & Antenatal Screening

Miscarriage and ectopic pregnancy Antenatal screening and early-pregnancy comparisons

23 Hypertensive Disorders of Pregnancy & Medical Complications in Pregnancy

Pregnancy hypertension and preeclampsia Eclampsia, HELLP and antepartum bleeding

24 Intrapartum Monitoring, Postpartum Haemorrhage & Obstetric Emergencies

Labour physiology and CTG assessment CTG response and postpartum haemorrhage Obstetric emergencies and preterm birth

25 Abnormal Uterine Bleeding, Pelvic Pain & Endometriosis

Abnormal bleeding and structural causes Endometrial sampling and endometriosis PCOS diagnosis and long-term care

26 Contraception, Emergency Contraception & Pregnancy Termination

Contraceptive choice and missed pills Emergency contraception and abortion

27 Australian Cervical Screening Program & Gynaecological Malignancies

Cervical screening and cervical cancer Endometrial and ovarian cancer

28 Neonatal Resuscitation, Congenital Conditions & Neonatal Jaundice

Newborn resuscitation, Apgar and cyanosis Neonatal jaundice assessment Jaundice treatment and congenital screening

29 Developmental Milestones, Growth Charts & Failure to Thrive

Developmental milestones Regression, autism and support Faltering growth and developmental comparisons

30 The Limping Child, Septic Arthritis vs Transient Synovitis & Paediatric Hip Conditions

Limp assessment and septic-joint risk Joint-infection management and Perthes disease SUFE and paediatric hip comparisons

31 Croup, Bronchiolitis, Paediatric Asthma & Anaphylaxis

Croup Bronchiolitis Paediatric asthma Paediatric anaphylaxis

32 Evaluation of the Febrile Child, Sepsis & Meningococcal Disease

Febrile neonates and young infants Meningococcal disease and paediatric sepsis Bacterial meningitis and CSF interpretation Kawasaki disease and follow-up

33 Paediatric Surgical Abdomen, Dehydration & Child Protection / Non-Accidental Injury

Pyloric stenosis Intussusception and dehydration Child protection and injury assessment

34 The Mental State Examination & Suicide Risk Stratification

Mental state examination and psychotic symptoms Suicide formulation and mental health law

35 Major Depressive Disorder, Bipolar Affective Disorder & Mood Stabilisers

Depression assessment and treatment Serotonin toxicity and bipolar presentations Mood stabilisers and ECT

36 Generalised Anxiety, Panic Disorder, PTSD & Obsessive-Compulsive Disorder

Anxiety, panic and agoraphobia OCD and trauma-related disorders

37 Schizophrenia, Acute Psychosis & Antipsychotic Management

Psychosis assessment and antipsychotics Clozapine and severe adverse effects

38 Substance Use Disorders & Acute Withdrawal Syndromes

Substance disorders and alcohol withdrawal Wernicke disease, opioids and stimulants

39 Delirium vs Dementia, Perinatal Mood Disorders & Paediatric Psychiatry

Delirium and dementia assessment Cognitive behaviour, perinatal and childhood psychiatry

40 Medicare, PBS, AHPRA & Good Medical Practice Framework

Australian health services and Medicare PBS access and professional registration Professional boundaries and notifications

41 Informed Consent (Rogers v Whitaker), Mental Capacity & Involuntary Treatment

Consent, material risks and young people Capacity, refusal and substitute decisions

42 Patient Privacy, Confidentiality Exceptions & Mandatory Notifications

Privacy, disclosure and child reporting Driving fitness and threat disclosure

43 First Nations health and preventive care

First Nations health, determinants and cultural safety Community care, Item 715 and CTG medicines Immunisation and cancer screening entry points Screening pathways and primary CVD prevention

44 Epidemiological Metrics, Clinical Study Designs & Notifiable Communicable Diseases

Epidemiology, calculations, bias and surveillance

45 Neurological presentations

Stroke, TIA and focal weakness Headache, facial pain and vertigo Seizures, collapse and altered consciousness Numbness, movement disorders and generalised weakness

46 Musculoskeletal pain

Back, neck, bone and soft tissue pain

47 Eye presentations

Altered vision and retinal disease Red eye, ocular injury and discharge

48 Ear, nose, throat and oral health

Ear pain, hearing loss and tinnitus Nasal problems, neck lumps, hoarseness and dysphagia Toothache, mouth symptoms, dry mouth and halitosis

49 Skin, hair and nails

Rash, itch, infection and skin ulcers Skin lesions, hair loss and nail abnormalities

50 Breast health and feeding

Breast lumps, discharge and breastfeeding problems

51 Sexual and reproductive presentations

Genital symptoms, discharge and pelvic infection Menopause, prolapse and urinary symptoms Infertility and sexual dysfunction

52 Palliative care and carers

The dying patient, symptoms and carers

53 Eating disorders and personality care

Eating disorders, obesity and weight change Personality difficulties, self-harm and complex care

54 Sleep presentations

Insomnia, snoring and daytime sleepiness

55 Poisoning, resuscitation and environmental emergencies

Poisoning, toxidromes and antidote decisions Cardiopulmonary arrest, choking and emergency help Bites, stings, heat, cold and drowning

56 Communication, rights and professional practice

Communication, handover, errors and complaints Healthcare rights, inclusive care and equitable access Certificates, deaths, CPD and supervision Telehealth, images, prescribing and doctors' health

57 Genetics, research and donation

Genetic testing, research and organ donation

58 Travel, fever and outbreaks

Fever, travellers and outbreak response

Psychosis assessment and antipsychotics

Key Takeaways Explain This Topic AI

Monitor metabolic effects during antipsychotic treatment.

Long-acting injections can support treatment when suitable and agreed.

Negative symptoms and functional impairment need care beyond control of hallucinations.

Last updated: October 2026

Schizophrenia, Acute Psychosis & Antipsychotic Management

Psychotic disorders represent profound disturbances in reality testing, thinking, perception, and behaviour. In Australian clinical practice, distinguishing between primary psychotic illnesses (such as schizophrenia and schizoaffective disorder) and secondary organic psychoses is a critical diagnostic competency assessed in the AMC examination. Prompt recognition of extrapyramidal movement disorders, metabolic complications, and medical emergencies such as Neuroleptic Malignant Syndrome (NMS) and clozapine-induced agranulocytosis is vital for patient safety.

Diagnostic Framework: Schizophrenia and Psychotic Spectrum Disorders

The Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) categorizes psychotic disorders along a continuum defined by duration, symptom profile, and functional impairment.

DSM-5 Diagnostic Criteria for Schizophrenia

To establish a diagnosis of schizophrenia, the patient must fulfill three primary criteria:

Criterion A (Active-Phase Symptoms) : Two (or more) of the following five symptoms present for a significant portion of time during a one-month period (or less if successfully treated). At least one symptom must be item 1, 2, or 3:

1. Delusions : Fixed false beliefs impervious to contrary evidence (persecutory, grandiose, reference, somatic, or passivity/control).

2. Hallucinations : Perceptual experiences without external sensory stimuli (auditory running commentary or voices conversing in the third person are classic).

3. Disorganized Speech : Formal thought disorder reflected in speech (frequent derailment, loosening of associations, incoherence, neologisms).

4. Grossly Disorganized or Catatonic Behaviour : Unpredictable agitation, catatonic stupor, waxy flexibility, posturing, or inappropriate bizarre actions.

5. Negative Symptoms : Diminished emotional expression (blunted affect), avolition (lack of initiative), alogia (poverty of speech), anhedonia, and asociality.

Social and Occupational Dysfunction : Marked decline in one or more major areas of functioning (work, interpersonal relations, self-care) below the level achieved prior to onset.

Continuous Duration : Continuous signs of disturbance persisting for at least six months . This six-month window must include at least one month of active-phase symptoms (Criterion A), and may include prodromal or residual periods of attenuated symptoms.

Differential Diagnosis of Psychotic Disorders

Brief Psychotic Disorder : Sudden onset of at least one psychotic symptom lasting at least one day but less than one month , with eventual full return to premorbid functioning. Frequently precipitated by severe psychological stressors.

Schizophreniform Disorder : Fulfills Criterion A for schizophrenia, with the total duration of the illness (including prodromal, active, and residual phases) lasting at least one month but less than six months . If symptoms persist past six months, the diagnosis transitions to schizophrenia.

Schizoaffective Disorder : An uninterrupted illness episode characterized by the concurrent presence of a major mood episode (major depressive episode or manic episode) alongside Criterion A of schizophrenia. Crucially, to differentiate schizoaffective disorder from a mood disorder with psychotic features, the patient must experience delusions or hallucinations for at least two consecutive weeks in the absence of prominent mood symptoms at some point during the lifetime course of the illness.

Bipolar I Disorder with Psychotic Features : Psychotic symptoms occur exclusively during an acute manic or severe depressive episode. When the affective disturbance resolves, psychotic symptoms remit completely.

Substance/Medication-Induced Psychotic Disorder : Psychosis developing during or immediately after substance intoxication (e.g., methamphetamine, synthetic cannabinoids, cocaine) or withdrawal, or following prescription medication (e.g., high-dose corticosteroids).

Medical assessment in first-episode psychosis

Obtain a physical and neurological examination, observations and glucose; ask about medicines, substances, sleep and temporal course, with collateral where appropriate. Fluctuating attention suggests delirium. Seizures, focal signs, autonomic instability, abrupt cognitive deterioration or unusual age of onset warrant a targeted neurological/medical workup.

Baseline blood tests commonly include FBC, electrolytes, kidney/liver function, calcium, thyroid function and metabolic measures before antipsychotic treatment. Select B12/folate, HIV/syphilis testing, toxicology and neuroimaging according to risks, findings and the local first-episode pathway, with appropriate consent. Do not label every conceivable test obligatory for every well young person.

Suspected encephalitis may require LP, EEG and CSF antibodies. Rapid psychiatric change with seizures and dysautonomia raises anti-NMDA receptor encephalitis, including an ovarian-teratoma association. A urine drug screen is only an adjunct: it may miss substances, remain positive after intoxication or have false positives. A primary psychiatric diagnosis requires a clinical longitudinal assessment, not simply a normal test panel.

Antipsychotic Pharmacotherapy: FGAs vs SGAs

Antipsychotic medications are the cornerstone of pharmacotherapy for schizophrenia. They are classified into first-generation (typical) and second-generation (atypical) antipsychotics based on their pharmacological receptor binding profiles.

Dopamine Pathways and Therapeutic Mechanism

Mesolimbic Pathway : Hyperactivity of dopamine in this pathway mediates positive psychotic symptoms (delusions, hallucinations). Antipsychotics exert their therapeutic effect by blocking dopamine D2 receptors in this pathway.

Mesocortical Pathway : Hypoactivity of dopamine here contributes to negative symptoms and cognitive deficits. Non-selective D2 blockade can inadvertently worsen negative symptoms.

Nigrostriatal Pathway : Part of the extrapyramidal motor system. D2 receptor blockade here produces extrapyramidal side effects (EPSE).

Tuberoinfundibular Pathway : Dopamine tonically inhibits prolactin release from the anterior pituitary. D2 blockade disinhibits prolactin release, causing hyperprolactinaemia.

First-Generation Antipsychotics (FGAs)

Agents : Haloperidol, chlorpromazine, zuclopenthixol, flupentixol.

Pharmacodynamics : High-affinity antagonism of dopamine D2 receptors. Highly effective against positive symptoms but carry a substantial risk of extrapyramidal movement disorders.

Extrapyramidal Side Effects (EPSE) Spectrum :

Acute Dystonic Reaction (Hours to Days): Sudden, painful, sustained spastic muscle contractions. Manifestations include torticollis (neck twisting), oculogyric crisis (involuntary upward gaze deviation), trismus (jaw clenching), and potentially fatal laryngeal dystonia. Treatment : Immediate anticholinergic medication— benztropine 1 − 2 mg 1-2\text{ mg} 1 − 2 mg IM or IV (or diphenhydramine), providing rapid relief within minutes.

Akathisia (Days to Weeks): Intense subjective psychic restlessness accompanied by an objective compulsion to move (pacing, inability to sit still, rocking from foot to foot). Often misdiagnosed as worsening psychotic agitation. Treatment : Antipsychotic dose reduction, switching to an agent with lower liability (e.g., quetiapine), or adding a lipophilic beta-blocker ( propranolol 10 − 40 mg 10-40\text{ mg} 10 − 40 mg bd/tds ) or short-term benzodiazepine (clonazepam).

Parkinsonism (Weeks to Months): Bradykinesia, cogwheel rigidity, masked facies, resting tremor, and festinating gait. Treatment : Dose reduction, switching to a second-generation agent, or temporary oral anticholinergic (benztropine 1 − 2 mg 1-2\text{ mg} 1 − 2 mg daily).

Tardive Dyskinesia (TD) (Months to Years): Involuntary, repetitive, choreoathetoid movements predominantly affecting the tongue, lips, perioral muscles (lip-smacking, tongue-protrusion, chewing movements), and extremities. Pathophysiology involves postsynaptic D2 receptor upregulation and supersensitivity following prolonged dopamine blockade. Crucial Rule : Anticholinergic drugs (benztropine) worsen tardive dyskinesia and must be ceased. Management involves gradual tapering/cessation of the causative FGA, switching to clozapine, or treatment with vesicular monoamine transporter 2 (VMAT2) inhibitors (valbenazine, deutetrabenazine).

Primary references (checked 7 October 2026): Australian clozapine product information .